{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:06Z","timestamp":1792431966612,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ijid.2020.08.032","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:54:24Z","timestamp":1597391664000},"page":"437-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate"],"prefix":"10.1016","volume":"99","author":[{"given":"Mathieu","family":"Gendrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Duflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Boxberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Delandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Jardot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Le Bideau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Fonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Mosnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"La Scola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.08.032_bib0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1475-2875-9-275","article-title":"Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine","volume":"9","author":"Ali","year":"2010","journal-title":"Malar J"},{"issue":"101632","key":"10.1016\/j.ijid.2020.08.032_bib0010","article-title":"Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infection diseases referral hospital in Marseille, France, -January 31 to March 1, 2020: A respiratory virus snapshot","volume":"20","author":"Amrane","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2020.08.032_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijid.2020.08.032_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-3156.2006.01785.x","article-title":"Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria","volume":"12","author":"Ashley","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2020.08.032_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.ijid.2020.08.032_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ijid.2020.08.032_bib0035","doi-asserted-by":"crossref","first-page":"e002699","DOI":"10.1136\/bmjgh-2020-002699","article-title":"The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study","volume":"5","author":"Diop","year":"2020","journal-title":"BMJ Glob Health"},{"issue":"133","key":"10.1016\/j.ijid.2020.08.032_bib0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model","author":"Fan","year":"2020","journal-title":"Chin Med J"},{"key":"10.1016\/j.ijid.2020.08.032_bib0045","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"395","key":"10.1016\/j.ijid.2020.08.032_bib0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(20)30411-6","article-title":"Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study","author":"Gilbert","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.08.032_bib0055","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.ijid.2020.08.032_bib0060","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1017\/S0950268820000424","article-title":"Passengers\u2019destinations from China: low risk of novel coronavirus (2019-nCoV) transmission into Africa and South America","volume":"148","author":"Haider","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2020.08.032_bib0065","doi-asserted-by":"crossref","first-page":"e00060","DOI":"10.1128\/AAC.00060-19","article-title":"Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults","volume":"63","author":"Hanboonkunupakarn","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"395","key":"10.1016\/j.ijid.2020.08.032_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","author":"Huang","year":"2020","journal-title":"China. Lancet"},{"key":"10.1016\/j.ijid.2020.08.032_bib0075","article-title":"Optimal temperature zone for dispersal of COVID-19","volume":"16","author":"Huang","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.ijid.2020.08.032_bib0080","series-title":"Countries which primarily use antimalarial drugs as COVID-19 treatment see slower dynamic of daily deaths","author":"Izoulet","year":"2020"},{"key":"10.1016\/j.ijid.2020.08.032_bib0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/AAC.03829-14","article-title":"Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adults Thai subjects","volume":"59","author":"Jittamala","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2020.08.032_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0379-0738(94)90376-X","article-title":"Mefloquine distribution in postmortem cases","volume":"68","author":"Jones","year":"1994","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.ijid.2020.08.032_bib0095","first-page":"e54","article-title":"Cross-protection induced by Encephalitis vaccines against COVID-19 might be a reason for relatively lower mortality rate in some countries","volume":"8","author":"Katoh","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.ijid.2020.08.032_bib0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12688\/aasopenres.13061.1","article-title":"COVID-19: Are Africa\u2019s diagnostic challenges blunting response effectiveness?","volume":"3","author":"Kobia","year":"2020","journal-title":"AAS Open Res"},{"key":"10.1016\/j.ijid.2020.08.032_bib0105","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-009-0656-1","article-title":"Tolerability and phramacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers","volume":"65","author":"Navaratnam","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2020.08.032_bib0110","first-page":"590707","article-title":"Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats","author":"Park","year":"2010","journal-title":"J Biomed Biotech"},{"issue":"25","key":"10.1016\/j.ijid.2020.08.032_bib0115","first-page":"2000543","article-title":"Projected early spread of COVID-19 in Africa through June 1, 2020","author":"Pearson","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2020.08.032_bib0120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2020.08.032_bib0125","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/jac\/dku154","article-title":"Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso","volume":"69","author":"Valea","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2020.08.032_bib0130","article-title":"High temperature and high humidity reduce the transmission of COVID-19","author":"Wang","year":"2020","journal-title":"SSRN Electron J."},{"key":"10.1016\/j.ijid.2020.08.032_bib0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.2042-7158.1988.tb05264.x","article-title":"Tissue distribution and excretion of amodiaquine in the rat","volume":"40","author":"Winstanley","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ijid.2020.08.032_bib0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2020.08.032_bib0145","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","article-title":"Antimalarial agent artesunate inhibits TNF-alpha-induced production of pro-inflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumathology"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220306615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220306615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:55:24Z","timestamp":1761119724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220306615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":29,"alternative-id":["S1201971220306615"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.08.032","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}